...Mohamed G. Soliman; Shawky El-Abd; Osama M. El-Gamal; Ali Abdel Raheem; Ahmed R. Abou-Ramadan; Ahmed S. El-Abd Purpose: The purpose of this study is to investigate the efficacy and safety of mirabegron versus solifenacin in the treatment of newly diagnosed overactive bladder (OAB) in children...

...Hai-Tao Wang; Ming Xia Objectives: This meta-analysis was to assess solifenacin and tolterodine in patients with overactive bladder. Methods: We searched PubMed, the Cochrane Library, EMBASE, CNKI, Wanfang, and ClinicalTrials.gov databases for randomized controlled trials (RCTs). The efficacy...

...Christian Hampel; Dietmar Betz; Maximilian Burger; Christoph Nowak; Monika Vogel Introduction: The study aimed to evaluate the efficacy and safety of solifenacin in older patients with overactive bladder (OAB). Materials and Methods: Observational data on patients aged ≥70 years and the prescribed...

...Carlo Vecchioli Scaldazza; Carolina Morosetti Introduction: We assessed clinical and urodynamic effects of solifenacin versus mirabegron in women with overactive bladder (OAB) syndrome. Material and Methods: Eighty women with OAB were randomized into 2 groups. In group A, the patients received...

... according to the method of treatment as follows: group А1: n = 57, trospium 30 mg/day + solifenacin 10 mg/day; group А2: n = 61, trospium 15 mg/day + solifenacin 5 mg/day; group А3: n = 59, placebo. All patients underwent a urodynamic examination in accordance with international standards before and 2...

...Yasin Aydoğmuş; Melih Sunay; Hüseyin Arslan; Arif Aydın; Ali Kudret Adiloğlu; Hünkar Şahin Objective: To determine whether acupuncture is effective as an overactive bladder (OAB) treatment compared with solifenacin and placebo, and to investigate its relation with urine nerve growth factor (NGF...

...Teruhiko Yokoyama; Takao Koide; Ryoei Hara; Kazuhiko Fukumoto; Yoshiyuki Miyaji; Atsushi Nagai Objective: The aim of this study was to assess the efficacy and safety of long-term treatment with two different antimuscarinics, imidafenacin and solifenacin, in patients with overactive bladder (OAB...